Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain–Barré syndrome
- 15 September 2001
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 190 (1-2) , 41-47
- https://doi.org/10.1016/s0022-510x(01)00580-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndromeAnnals of Neurology, 1998
- IgM anti-GM1 antibodies in the Guillain–Barré syndrome: a serological predictor of the clinical courseJournal of Neuroimmunology, 1997
- Anti‐GD1a ganglioside antibodies in peripheral motor syndromesAnnals of Neurology, 1996
- IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclassesJournal of Neuroimmunology, 1995
- Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller fisher syndromeJournal of Neuroimmunology, 1994
- Electroneurography index: A standardized neurophysiological method to assess peripheral nerve function in patients with polyneuropathyMuscle & Nerve, 1993
- Association of IgG anti‐GD1a antibody with severe Guillain–Barré syndromeMuscle & Nerve, 1993
- Cerebrospinal fluid anti-cardiolipin antibodies in neurological diseasesClinical Immunology and Immunopathology, 1991
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990
- Severe Guillain-Barré syndrome: An association with IgA anti-cardiolipin antibody in a series of 92 patientsJournal of Neuroimmunology, 1988